
    
      People living with HIV and matched HIV negative controls will be tested serologically for
      cysticercosis, examined neurologically and will undergo CT scanning to determine the
      prevalence and presentation of NCC.

      Furthermore, the immune system response in HIV patients with Taenia solium neurocysticercosis
      will be assessed.
    
  